Back
New York Community Bancorp Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
45
NYCB
New York Community Bancorp
Last Price:
11.46
Seasonality Move:
3.89%
Sell
18
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
21.00
Seasonality Move:
-9.84%
Sell
45
New York Community Bancorp (NYCB)
is a Sell
Is New York Community Bancorp a Buy, Sell or Hold?
- The current New York Community Bancorp [NYCB] share price is $11.46. The Score for NYCB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NYCB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $20.92. The Score for CRBP is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
NYCB Stock Price Chart
What is New York Community Bancorp's stock price today?
-
The New York Community Bancorp share price today is $11.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYCB is experiencing slight selling pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $20.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing selling pressure, which indicates risk of future bearish movement.
NYCB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.21 | Buy |
Relative Strength Index (14 RSI): | 55.87 | Buy |
Chaikin Money Flow: | -1020920 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.35 - 11.51) | Buy |
Bollinger Bands (100): | (9.62 - 11.12) | Buy |
CRBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.22 | Sell |
Relative Strength Index (14 RSI): | 26.63 | Sell |
Chaikin Money Flow: | -808540 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.3 - 61.4) | Sell |
Bollinger Bands (100): | (39.8 - 58.48) | Sell |
NYCB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.38 | Buy |
20-day SMA: | 10.93 | Buy |
50-day SMA: | 10.67 | Buy |
200-day SMA: | 14.06 | Sell |
8-day EMA: | 11.24 | Buy |
20-day EMA: | 11.04 | Buy |
50-day EMA: | 10.76 | Buy |
200-day EMA: | 14.44 | Sell |
CRBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.72 | Sell |
20-day SMA: | 43.43 | Sell |
50-day SMA: | 51.2 | Sell |
200-day SMA: | 37.41 | Sell |
8-day EMA: | 27.51 | Sell |
20-day EMA: | 38.64 | Sell |
50-day EMA: | 46.39 | Sell |
200-day EMA: | 38.73 | Sell |
New York Community Bancorp Earnings Growth & NYCB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.45 per share, an increase next quarter of $0.48 per share, a decrease this year of $6.32 per share, and an increase next year of $2.38 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.64 per share, an increase this year of $6.97 per share, and a decrease next year of $0.83 per share.
New York Community Bancorp Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corbus Pharmaceuticals Holdings Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |